A CRISPR-based strategy to promote endogenous fetal hemoglobin re-expression to treat sickle cell disease: my latest Nature Medicine column.
#SickleCell #GeneTherapy #Crispr
https://www.nature.com/articles/d41591-023-00088-6
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.